Effectively Combating Antimicrobial Resistance: Assessing the Clinical Outcomes of Antimicrobial Stewardship Intervention in Patients with Critical Priority Pathogens

1MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, INDIA

2Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, INDIA

3ICMR-PGIMER Advanced Center for Product Development, Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, INDIA

4MM Institute of Medical Sciences and Research, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, Haryana, INDIA

Corresponding author.

Correspondence: Dr. Anuj Malik Professor, MM College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala-133207, Haryana, INDIA. Email: doctarunmmu@gmail.com
Received November 01, 2024; Revised November 15, 2024; Accepted December 02, 2024.
Copyright 2024 Authors
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Citation

1.Singh T, Gupta S, Malik A, Mothsara C, Pandey A, Kaur N, et al. Effectively Combating Antimicrobial Resistance: Assessing the Clinical Outcomes of Antimicrobial Stewardship Intervention in Patients with Critical Priority Pathogens. Journal of Young Pharmacists [Internet]. 2024 Feb 15;16(1):50–7. Available from: http://dx.doi.org/10.5530/jyp.2024.16.7
Copy to clipboard
Published in: Journal of Young Pharmacists, 2024; 16(1): 50-57.Published online: 07 July 2025DOI: 10.5530/jyp.2024.16.7

ABSTRACT

Background

Amid the pressing global concern of Antimicrobial Resistance (AMR), where Antimicrobial Stewardship (AMS) stands as a promising solution in relation to this, critical priority has been assigned to AMR pathogens in the Indian Pathogen Priority List to steer research focused on antibiotic-resistant bacteria. The study’s particular objective is to assess how an AMS intervention affects these pathogens in adult patients.

Materials and Methods

Over a dedicated two-year period from January 2021 to November 2022 research focused on adult patients harboring critical priority pathogens, adhering to ICMR directives. The primary goal was to comprehend antimicrobial drug usage in hospital’s medicine and surgery unit. Employing a qualitative approach, study conducted a Prospective Audit with Feedback (PAF), implementing deliberate constraints on antimicrobial drug usage to gain insights.

Results

The analysis encompassed 314 participants: 96 in control phase, and 115 and 103 in the intervention phases 2 and 3. Comparable demographics and service scope existed between intervention and control groups. All arms exhibited the presence of culture-positive organisms from the critical priority pathogen list defined by ICMR. Impressively, length of therapy per 1000 patient days notably dropped from 908.50 to 758.33 (p=0.001) post-intervention.

Conclusion

The study’s conclusion highlights responsible antimicrobial use in a tertiary care setting, showcasing promising progress. Noteworthy impacts on the dependent variable (Log_LOT) emerged across study phases, emphasizing intervention significance. Statistically significant Ward and Phase variables further enriched the overall insights.

Keywords: Antimicrobial stewardship, Critical-priority pathogen, Prospective audit and feedback, Length of Treatment (LOT)